Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection

Fig. 1

Schematic of subject recruitment and serum sample analysis for WNV E IgG antibodies. a Subjects were recruited either from the general public (asymptomatic) and self-reported to have no previous history of WNV infection or in collaboration with the Department of Public Health (symptomatic) and previously diagnosed with WNV infection. Samples from both groups of subjects were analyzed as indicated. b Analysis of WNV anti-E glycoprotein antibodies (IgG) in the serum samples obtained from 408 subjects via ELISA

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us